Taletrectinib: TRUST in the Continued Evolution of Treatments for ROS1 Fusion–Positive Lung Cancer.

Details

Language :

English

ISSN :

0732183X

Volume :

42

Issue :

22

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

178686157

Full Text :

https://doi.org/10.1200/JCO.24.01062